SCHEMBL21779660

SCHEMBL21779660

CC(C)Cc1cc(N)cc(CN(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.43
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HRH3 Q9Y5N1 2/20 0.34
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
TTK P33981 1/20 0.31
AURKB Q96GD4 1/20 0.31
INCENP Q9NQS7 1/20 0.31
NOS1 P29475 3/20 0.31
NOS3 P29474 2/20 0.31
NOS2 P35228 2/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17916301 0.85 GABRA1 (0.39) ALDH1A1TSHRLMNACYP2C9GABRA1
SCHEMBL4643735 0.81 ALDH1A1 (0.50) GSRALDH1A1TSHRLMNAGAA
SCHEMBL9927095 0.81 GSR (0.43) GSRALDH1A1TSHRLMNAGAA
SCHEMBL21779670 0.78 GABRA1 (0.34) GABRA1GABRB2NOS1NOS3NOS2
SCHEMBL18949819 0.76 GABRA1 (0.33) GABRA1GABRB2NOS1NOS3NOS2
SCHEMBL19251069 0.74 GABRA1 (0.32) GABRA1GABRB2NOS1NOS3NOS2
SCHEMBL16640979 0.74 ALDH1A1 (0.50) GSRALDH1A1TSHRHRH3GABRA1
SCHEMBL2174853 0.74 ALDH1A1 (0.52) GSRALDH1A1TSHRLMNAGAA
SCHEMBL2528801 0.73 ALDH1A1 (0.55) GSRALDH1A1TSHRLMNAGAA
SCHEMBL1312347 0.73 GABRA1 (0.46) ALDH1A1TSHRLMNACYP2C9GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3245213-B1 BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING BRISTOL MYERS SQUIBB CO (US) 2020-03-04 EP disclosed